Close
AccueilOur news

Our news

EPI-PHARE carries out pharmacoepidemiology studies on health products in real life. Find here our news.

Search by
Keyword title
  • Call for proposals
  • Congress
  • EPI-PHARE
  • Publication
  • Study report
Period
EPI-PHARE 09/21/2022

Award

EPI-PHARE receives award from the American Heart Association
Read
EPI-PHARE 11/10/2021

14th Congress of the European Society of Gynecology

10-13 Novembre 2021 in Venise
Read
EPI-PHARE 05/04/2021

Job offers

2 doctoral positions and post-docs
Read
Call for proposals 12/08/2020

Call for proposals

Group leader in pharmaco-epidemiology
Read
Publication 09/16/2020

New publication in Alimentary Pharmacologiy & Therapeutics

Pregnancy in women with inflammatory bowel disease: a French nationwide study 2010-2018
Read
Publication 07/27/2020

Publication in Internationl Journal of Cancer

Risk of secondary hematologic malignancies associated with breast cancer chemotherapy and G‐CSF support:...
Read
Publication 07/16/2020

New publication in Scientific Reports

Oral anticoagulants and risk of acute liver injury in patients with nonvalvular atrial fibrillation: a...
Read
Study report 06/12/2020

Drug use in France during the Covid-19 pandemic

Report 3: Update after the end of the confinement
Read
Publication 06/10/2020

New publication in BMJ Open

Risk of early neurodevelopmental outcomes associated with prenatal exposure to the antiepileptic drugs...
Read
05/04/2020

Drug use in France during the Covid-19 pandemic

Report 2: Update after five weeks of confinement.
Read
Study report 04/21/2020

Drug use in France during the Covid-19 pandemic

Report 1: Update on the first two weeks of confinement.
Read
Congress 03/12/2020

Congress ADELF EMOIS 2020

EPI-PHARE takes part in the ADELF-EMOIS congress, on March 12 and 13, 2020 at the Cité Universitaire de...
Read
02/10/2020

Use of mycophenolate

Exposure to Mycophenolic Acid Products during pregnancy from 2010 to 2017 in France.
Read
12/01/2019

Follow-up of the use of Truvada® or generics for pre-exposure prophylaxis (PrEP) for HIV

EPI-PHARE publishes the updated data up to June 30, 2019 of the follow-up of use of Truvada® or generics...
Read
Call for proposals 09/17/2019

Results of the Call for proposals Partner Centers

EPI-PHARE publishes the results of the call for proposals for Partner Centers published last April.
Read
Congress 08/23/2019

35th ICPE

EPI-PHARE participates in the 35th International Conference on Pharmacoepidemiology & Therapeutic Risk...
Read
Study report 06/13/2019

Consequences of switching to the new Levothyrox formula in France

Read
Call for proposals 04/23/2019

Call for proposals : Partner Centers

EPI-PHARE offers funding for a maximum of 2 Partner Centers in epidemiology of health products independent...
Read
EPI-PHARE 01/22/2019

Creation of EPI-PHARE

At the end of December 2018, Dominique Martin, General Director of ANSM and Nicolas Revel, General...
Read
Afficher plus
Going further
Who are we ? Learn more
Study reports and publications Learn more